The median mutation frequencies of ASXL1 and SETBP1 in isolated CNL are 57.1% and 35.7%, respectively, and these alterations are poor prognostic factors for patients with CNL and CNL-PCD (12). This evidence concerns the gene ASXL1 and chronic neutrophilic leukemia.